Revvity, Inc. (NYSE:RVTY) Given Consensus Rating of “Moderate Buy” by Analysts

Revvity, Inc. (NYSE:RVTY) has received a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the firm, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $136.25.

Several equities analysts have recently weighed in on the company. Sanford C. Bernstein cut Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target for the company. in a research report on Friday, January 10th. Raymond James reaffirmed an “outperform” rating and set a $145.00 target price (up previously from $140.00) on shares of Revvity in a report on Monday, February 3rd. Barclays increased their price target on shares of Revvity from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. KeyCorp boosted their price objective on shares of Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Finally, Bank of America raised shares of Revvity from a “neutral” rating to a “buy” rating and set a $138.00 target price on the stock in a report on Friday, December 13th.

Insider Transactions at Revvity

In other Revvity news, insider Tajinder S. Vohra sold 5,492 shares of the business’s stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total value of $641,520.52. Following the completion of the sale, the insider now directly owns 19,652 shares of the company’s stock, valued at $2,295,550.12. The trade was a 21.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Joel S. Goldberg sold 15,170 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the sale, the insider now owns 33,400 shares of the company’s stock, valued at approximately $4,232,782. The trade was a 31.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Revvity

Institutional investors and hedge funds have recently bought and sold shares of the stock. Wealth Enhancement Advisory Services LLC lifted its position in Revvity by 26.7% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 4,114 shares of the company’s stock valued at $526,000 after purchasing an additional 868 shares during the last quarter. Asset Management One Co. Ltd. increased its stake in shares of Revvity by 1.3% in the third quarter. Asset Management One Co. Ltd. now owns 49,256 shares of the company’s stock worth $6,292,000 after buying an additional 621 shares during the period. Principal Financial Group Inc. raised its holdings in Revvity by 3.1% during the 3rd quarter. Principal Financial Group Inc. now owns 141,871 shares of the company’s stock valued at $18,124,000 after buying an additional 4,263 shares during the last quarter. Kornitzer Capital Management Inc. KS purchased a new stake in Revvity during the 3rd quarter valued at $233,000. Finally, Proficio Capital Partners LLC bought a new stake in Revvity in the 3rd quarter worth $202,000. 86.65% of the stock is currently owned by institutional investors.

Revvity Price Performance

Shares of NYSE:RVTY opened at $118.40 on Thursday. The firm has a market capitalization of $14.23 billion, a PE ratio of 53.58, a P/E/G ratio of 3.82 and a beta of 1.06. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. The company has a 50-day moving average price of $117.05 and a two-hundred day moving average price of $118.20. Revvity has a twelve month low of $97.32 and a twelve month high of $129.50.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Friday, January 31st. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period in the prior year, the firm posted $1.25 earnings per share. Equities analysts forecast that Revvity will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.24%. The ex-dividend date is Thursday, April 17th. Revvity’s dividend payout ratio (DPR) is currently 12.67%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.